#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-small cell lung cancer Small intestine leiomyosarcoma Anti-glomerular basement membrane disease Cognitive disorder Myelofibrosis Langerhans' cell histiocytosis Pseudoxanthoma elasticum Oesophageal adenocarcinoma Follicular lymphoma stage III Adrenocortical carcinoma Restless legs syndrome Paraneoplastic neurological syndrome Antiphospholipid antibodies Diffuse large B-cell lymphoma recurrent Mantle cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Trials in Disease Inclusion body myositis – Life with Disease IgA nephropathy – Basic Information Advanced systemic mastocytosis Rhabdomyosarcoma VEXAS syndrome – Trials in Disease Leiomyosarcoma – Trials in Disease Breast angiosarcoma metastatic – Life with Disease Friedreich’s ataxia – Life with Disease Sjogren’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pregabalin Iron Acemetacin Urapidil Phenol Sym025 Tulmimetostat Fentanyl Demeclocycline Hydrochloride Msv/As Blomia Tropicalis DUVELISIB Mbs2320 RNK001 Bgb-15025 Citrate ANTIMETABOLITES Crisantaspase Isoniazid NAVENIBART Amylase More therapies…

    Learn about Your Condition

    Chondrosarcoma Pneumonia chlamydial Retinopathy of prematurity Haemorrhage Chronic spontaneous urticaria Short-bowel syndrome Dermatomyositis Solitary fibrous tumour Influenza Amyloidosis Anal cancer stage II Metabolic disorder Post cardiac arrest syndrome Demyelination Diminished ovarian reserve More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on Tick-Borne Encephalitis: Evaluating T-Cell Responses Using Cytokine Release Assay in Healthy and Immunosuppressed Patients with TBE Vaccines

    Recruiting

    3 1 1 1
    Sweden

  • Study on the Effectiveness of the HPV Vaccine in Preventing HPV Infections in Men Who Have Sex with Men Aged 19-26 Using Cervarix

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Papilloma viral infection
    Investigated Drugs:
    • HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN ADJUVANTED BY AS04 ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED ON BACULOVIRUS HI-5 RIX4446 CELLS, TRICHOPLUSIA NI. DERIVED
    • HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN ADJUVANTED BY AS04 ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED ON BACULOVIRUS HI-5 RIX4446 CELLS, TRICHOPLUSIA NI. DERIVED
    The Netherlands

  • Study on the Effectiveness of High-Dose vs. Standard-Dose Quadrivalent Influenza Vaccine in Preventing Flu in Adults Aged 65-79 in Galicia, Spain

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224)
    • B/Washington/02/2019 – Like Virus (B/Washington/02/2019, Wild Type)
    • INFLUENZA VIRUS A/DARWIN/9/2021 IVR-228 (H3N2)
    Spain

  • Study of Different Doses of MVA-BN Vaccine Booster for Adults with Mpox: Comparing Standard and Reduced Doses

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Monkeypox
    Investigated Drugs:
    • Modified Vaccinia Ankara – Bavarian Nordic Live Virus
    The Netherlands

  • Study on the Effects of the Dengue Vaccine Qdenga on Antibody Levels in Swedish Travelers

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dengue fever
    Sweden

  • Study comparing intranasal COVID-19 vaccine (LVT-001) with mRNA vaccine (bretovameran) as booster doses in healthy adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • LVT-001
    France
Previous Page
1 … 5 6 7 8 9 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!